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Abstract.  The bemagglutinin-neuraminidase  (HN) gly- 
coprotein of the paramyxovirus SV5 is a type II inte- 
gral membrane protein that is expressed at the infected 
cell surface.  The intracellular  assembly and transport 
of HN in CV1 cells was examined using conformation- 
specific HN mAbs and sucrose density sedimentation 
analysis.  HN,was found to oligomerize with a t,~ of 
25-30 min and these data suggest the oligomer is a 
tetramer consisting primarily of two noncovalently as- 
sociated disulfide-linked dimers.  As HN oligomers 
could be found that were sensitive to endoglycosidase 
H  digestion and oligomers formed in the presence of 
the ER to the Golgi complex transport inhibitor,  car- 
bonylcyanide m-chlorophenylhydrazone (CCCP), these 
data are consistent with HN oligomerization occurring 
in the ER.  Unfolded or immature HN molecules that 
could not be recognized by conformation-specific anti- 
bodies were found to specifically associate with the 
resident ER protein GRP78-BiE Immunoprecipitation 
of BiP-HN complexes with an immunoglobulin heavy- 
chain binding protein (BiP) antibody indicated that 
newly synthesized HN associated and dissociated from 
GRP78-BiP (t~ 20-25 min)  in an inverse correlation 
with the gain in reactivity with a  HN conformation- 
specific antibody, suggesting that the transient associa- 
tion of GRP78-BiP with immature HN is part of the 
normal  HN maturation pathway.  After pulse-labeling 
of HN in infected cells, it was found that HN is rap- 
idly turned over in cells (t~ 2-2.5 h).  This led to the 
finding that the vast majority of HN expressed at the 
cell surface, rather than being incorporated into bud- 
ding virions,  is internalized  and degraded after local- 
ization to endocytic vesicles and lysosomes. 
V 
IRAL envelope glycoproteins have  frequently  been 
used as model systems in the study of transport in the 
exocytic  pathway  e.g.,  the  hemagglutinin  protein 
(HA)  ~ of influenza virus and the glycoprotein ((3) of VSV. 
Both HA and G are class I integral membrane proteins that 
are oriented in the ER with an NH2-terminal  ectodomain 
and a COOH-terminal cytoplasmic tail  (reviewed  in refer- 
ence 57). Assembly into noncovalently  linked homotrimers 
is thought to occur in the ER before transport through  the 
exocytic pathway (5, 6, 14) and this assembly is fairly rapid 
(t~ 7-10 rain for HA [14] and t~ 6-8 min for G [7]).  It has 
been proposed from studies using wild-type and mutant mol- 
ecules that do not fold correctly that native folding and oligo- 
merization  may be a prerequisite for transport out of the ER 
and thus it may be a rate-limiting  step (14, 28, reviewed in 
reference 57).  The exact nature of the signals  and macro- 
1. Abbreviations used in this paper: BiP, binding protein; CCCP, carbonyl- 
cyanide m-chlorophenylhydrazone; F, fusion protein; G, glycoprotein; HA, 
hemagglutinin protein; HN, hemagglutinin-neuraminidase;  MNT buffer, 20 
mM morpholino-ethanesulfonic  acid;  p.i., postinfcction. 
molecular interactions  which are necessary for this apparent 
requirement are unknown although it has been observed that 
the resident ER protein,  immunoglobulin  heavy-chain bind- 
ing protein (BiP) (18), is associated with unfolded and mal- 
folded mutant  molecules of HA (14).  However,  it has not 
been determined if the association of BiP with HA is part of 
the normal maturation  pathway of HA or if BiP is only in- 
volved with improperly folded molecules. Evidence in sup- 
port of a role of BiP in the maturation  and assembly of pro- 
teins came from studies  using  lymphoid-derived cell lines. 
BiP was found to be associated with Ig heavy chains in non- 
secreting  pre-B cell lines and to Ig precursors in secreting 
hybridomas and myelomas but not with the completely as- 
sembled protein  (H21~) (1,  20).  It was hypothesized that 
BiP prevented  the transport of incompletely assembled Ig 
chains,  insuring  that  only  fully assembled proteins  were 
transported (1, 20). 
Recently, BiP has been identified as identical  to the glu- 
cose-regulated protein, GRP78 (22, 43), a highly conserved 
cellular protein (here designated GRP78-BiP) that is a mem- 
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has been found in all cell types examined and synthesis of 
GRP78-BiP can be stimulated by various perturbations such 
as glucose deprivation, inhibition of glycosylation, interfer- 
ence of intracellular calcium concentrations, infection with 
paramyxoviruses such as SVS, and the presence of malfolded 
proteins in the ER (10, 27, 50, 54, 69). Although the function 
of GRP78-BiP is unclear, it has been proposed to have a role 
in the folding and assembly of proteins in the exocytic path- 
way (1,  !4, 20, 21, 44, 47), to mark aberrantly folded pro- 
teins destined for degradation (9, 25, 34), or to aid in solu- 
bilizing aggregated proteins during periods of stress (43). 
Viral envelope proteins have also been used as models to 
study aspects of the endocytic pathway. When VSV G is ex- 
pressed in cells transfected with recombinant DNA mole- 
cules it is slowly internalized from and returned to the cell 
surface in a process similar to that found for recycling cellu- 
lar receptor molecules (17, 37, 51, 58). In addition, when G 
is directly implanted on the apical surface of polarized cells, 
it is internalized and transported to the basolateral surface, 
where it is normally resident (37, 51). In contrast, influenza 
HA normally accumulates in a stable manner at the cell sur- 
face and is not internalized. However, when the HA cytoplas- 
mic tail was replaced with that of VSV G, HA became inter- 
nalized, suggesting that an internalization signal lies in the 
cytoplasmic tail.  It has also been shown with HA that a 
properly positioned tyrosine residue is required in the cyto- 
plasmic tail for recycling to occur (31), as was hypothesized 
for the LDL receptor molecule (15). Although these studies 
are few in number, they have shown that well-characterized 
viral membrane glycoproteins can also be useful model sys- 
tems for understanding processes in the endocytic pathway. 
In paramyxovirus-infected cells two virns-specific integral 
membrane glycoproteins, the hemagglutinin-neuraminidase 
(HN) and the fusion protein (F) are synthesized. These pro- 
teins are synthesized on membrane-bound polysomes, and 
are  inserted into the ER and transported via the exocytic 
pathway to the cell surface (reviewed in reference 53). Like 
influenza HA and VSV G, the F glycoprotein is a class I gly- 
coprotein inserted into membranes with a NH2-terminal  ec- 
todomain, whereas HN is a class II integral membrane pro- 
tein  which  has  an  uncleaved NH2-terminal  signal/anchor 
domain and a  COOH-terminal  ectodomain (23,  24,  45). 
Both glycoproteins are incorporated into virions where HN 
mediates receptor-binding activities (hemagglutination) and 
F mediates membrane fusion activity with target cells (61, 
62).  In  addition,  HN  has  a  receptor-destroying  activity 
(neuraminidase) that is thought to be important in the release 
of progeny virus from cells (reviewed in reference 4). 
In this study, we have examined the folding, oligomeric as- 
sembly, and transport in the exocytic pathway of the SV5 HN 
glycoprotein as a model class II integral membrane protein. 
These experiments were greatly facilitated by using antibod- 
ies specific for different conformational states of the protein. 
We provide data that indicate that GRP78-BiP specifically 
and transiently associates with HN as part of the normal 
maturation pathway. Additionally, we unexpectedly find that 
HN is rapidly turned over in cells and this is because once 
HN is expressed at the cell surface it is internalized and 
localized ~to endosomal vesicles and lysosomes. 
Materials and Methods 
Cells and Virus 
The TC7 clone of  CVl cells and a variant of  the Madin-Darby bovine kidney 
cell line (MDBK) were grown and maintained in DME supplemented with 
10% FCS. The W3A strain of SV5 was grown in MDBK monolayer cultures 
as described previously (45). 
Antibodies 
The  purified  IgG  fraction  of rabbit  polyclonal  antisera  raised  against 
purified SV5 HN was that used previously (39, 40). The isolation of mouse 
mAbs specific to HN (HN-lb and HN-4b) and to F (F-la) has been described 
previously (56). mAbs HN-Ib and HN4b were shown to bind different anti- 
genic sites on HN by radioimmune competition assay (56). A rat mAb (anti- 
BiP), specific for the cellular heavy-chain binding protein (BiP), was kindly 
provided by Drs. Linda Hendershot (St. Jude Children's Research Hospital, 
Memphis, TN) and John E Kearney, (University of Alabama, Birmingham, 
AL) (1). All antisera described were titrated using an immunoprecipitation 
assay and were then used in all experiments under conditions of antibody 
excess. 
Viral Infection and Metabolic Labeling of Cells 
SV5-infected CVI cells were used in all the biochemical studies. CV1 cells 
were washed in PBS and infected with SV5 at "~20 plaque-forming units/cell 
in DME containing 0.5 % BSA for I h at 37°C. Cells were washed with DME 
and the medium was replaced with DME supplemented with 2% FCS. In- 
fected cells were maintained at 37°C in an atmosphere containing 5% CO2. 
Metabolic labeling of cells was typically carded out 14-16 h after infection 
(p.i.). In protocols in which a short radioactive labeling period was required 
followed by  incubations  in  unlabeled medium  (cold chase),  cells were 
washed twice with PBS,  and  incubated with cysteine- and methionine- 
deficient DME (DME cys-/met-) for 30 min. Cells were then labeled with 
50-100/tCi  Tran[3SS]-label  (ICN  Radiochemicals, Irvine, CA) in DME 
cys-/met- and incubated at 37°C for the duration of the pulse. A cold chase 
was initiated by removal of the labeling medium and immediately replacing 
it with premed  chase medium consisting of DME, 2 mM unlabeled cys- 
teine and methionine, and 2 % FCS. The chase period was terminated by 
washing cells in ice-cold PBS followed with lysis in an appropriate detergent 
buffer for immunoprecipitation. In protocols where steady state labeling was 
required,  cells were washed once in DME cys-/met- and  incubated in 
labeling medium that consisted of a  1:5 mix of DME to DME cys-/met- 
supplemented with 2% FCS and 100 ~Ci/ml [3SS]methionine  (Amersham 
Corp., Arlington Heights, IL). 
Immunoprecipitation,  SDS-PAGE, and Quantitation 
of  Autoradiograms 
Immunopreciphation of HN  from labeled infected-cell lysates was per- 
formed essentially as described unless where indicated (30).  SDS-PAGE 
was done as described (29). Autoradiograms were qnantitated by scanning 
densitometry on variable exposures of each gel to assure being within the 
linear range of the film. Densitometry and integration was performed as de- 
scribed (23). 
Immunoprecipitation of proteins from sucrose gradient fractions was 
done by diluting fractions eightfold with 1% NP-40, 0.05%  SDS, 50 mM 
Tris pH 7.4, and 150 mM NaCI (dilution buffer). The appropriate antibody 
was then added and samples incubated at 4°C for 3 h. 30 #1 of a  1:1 slurry 
of Staphylococcus  aureus  protein A-agarose beads (Calbiochem-Behring 
Corp., La Jolla, CA) were then added and rocked for 60 rain at 4°C to 
precipitate antibody-antigen complexes. The beads were then washed five 
times in dilution buffer and once in nondetergent wash buffer (150  mM 
NaCI, 50 mM Tris pH 7.4,  and 5 mM EDTA) before the complexes were 
boiled for 5 min in SDS-PAGE sample loading buffer. 
Coprecipitation of HN/GRP78-BiP was done under ATP-depleting con- 
ditions. Radioactively labeled cells were washed once in ice-cold PBS and 
lysed in 50 mM Tris pH 7.4,  150 mM NaCI, and 1% Triton X-100 (TNT 
buffer) containing  10  mM  glucose and  2  IU  hexokinase (Calbiochem- 
Behring Corp.).  Immunoprecipitation was then carded out as described 
above except that immune complexes were washed in TNT buffer and all 
steps were performed at 0-4°C. 
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point of incubation of antigen-antibody complexes with protein A-agarose 
beads. The beads were pelleted by centrifugation and the supernatant trans- 
ferred to a second tube. The beads were then washed with 50/~l of TNT 
buffer  and this wash supernatant  was pooled  with the previous  supernatant. 
The appropriate antibody  was then added to the combined  supernatants in 
the second  tube  and the procedure  repeated  as many  times  as required. Pro- 
tein A-agarose beads containing bound immune  complexes  from  the serial 
immunoprecipitations  were  washed with wash buffer  and prepared  for SDS- 
PAGE as described above. 
Sucrose Density Gradient Sedimentation Analysis of 
HN Oligomers 
The procedure used to analyze the rate of HN oligomerization was modified 
from that described (5). SVS-infected C'V1 cells (60-ram plates) were pulse 
labeled for 5 rain with Tran[35S]-Iabel  and incubated with chase medium 
for varying times. Cells were then lysed in 0.5 ml detergent buffer (20 mM 
morpholino-ethanesulfonic  acid, 30 mM Tris, 100 mM NaCI [MNT buffer] 
pH 5.0 and 1% Triton X-100) and 1% aprotinin. Nuclei and cell debris were 
removed by eentrifugation for 10 min in a microfuge and the lysate superna- 
taut was layered over the top of a continuous 7.5-22.5%  wt/vol sucrose/ 
MNT pH 5.0/0.1%  Triton X-100 gradient that overlaid a 0.75-ml 60%  su- 
crose cushion. The final volume was 12 ml. Gradients were centrifuged at 
38,000 rpm at 20"C for 20 h in a rotor (model SW41; Beckman Instruments, 
Inc., Palo Alto, CA). 24 0.5-ml fractions were collected dropwise from the 
bottom of  each gradient by puncturing the bottom of the tube. Aliquots from 
alternate fractions were then taken for immunoprecipitation, as described 
above. 
Endoglycosidase H Digestion 
HN was immunoprecipitated from infected-cell iysates as described above 
and  released  from  immune  complexes by  boiling  in  10  mM  Tris  pH 
7.4/0.4%  SDS. An equal volume of 0.1  M  Na-citrate (pH 5.3) and I  mU 
of Endo H  (Bochringer Mannheim Biochemicals, Indianapolis, IN) was 
then added and the samples were incubated for 24 h at 37°C. The reaction 
was terminated by the addition of SDS-PAGE sample loading buffer. 
Carbonylcyanide m-Chlorophenylhydrazone Treatment 
of Cells 
SV5-infected  cells were pulse-labeled for 10 rain as described above and im- 
mediately washed in cold PBS before addition of prechilled chase media 
containing 50 ~g/ml carbonylcyanide m-chlorophenylhydrazone (CCCP) 
(Sigma Chemical Co., St Louis, MO). After a  10-rain  incubation at 4°C, 
the cells were warmed to 37°C and incubated for 2 h before lysis. 
Indirect lmmunofluorescence Microscopy 
Coverslips of SV5-infected CVI cells were prepared for cell surface staining 
by fixing the cells in PBS containing 0.5%  methanol-free formaldehyde 
(Polysciences, Inc., Warrington, PA) for 5 rain at room temperature. For 
intracellular staining, the cells were formaldehyde fixed and permeabilized 
in acetone for 60 s at -20"C. Ascites fluids containing mAbs HN-lb and 
F-la were diluted 1:1,000 in PBS/I% BSA for localization of the HN and F 
proteins. Binding conditions and incubation with fluorescein-labeled sec- 
ond antibody was done as described previously (46), 
To assay for the internalization of surface bound antibody, SV5-infected 
CV1 cells were shifted to 4*(2. mAbs HN-Ib or F-la were added to the live 
cells and incubated for 30 min at 4°C. Cells were washed extensively in cold 
PBS to remove unbound antibody and then prewarmed (37°C) DME sup- 
plemeated with 2% FCS was added and cells were incubated at 37°C. For 
chloroquine treatment, cells were preincubated for 2 h in medium contain- 
ing 100 pM chloroquine before addition of antibody and were maintained 
in the same medium after the temperature shift. At various times following 
the temperature shift cells were fixed, or fixed and permeabilized, as de- 
scribed above. FITC-conjugated goat anti-mouse antibody (Organon Tech- 
nica Corp., West Chester, PA) was then added to detect the bound antibody. 
Photomicroscopy was performed using epifluorescent optics on an Ax- 
iophot (Carl Zeiss, Inc., Thornwood, NY) microscope. 
Results 
Rate of Oligomerization of  HN 
The HN integral membrane glycoprotein  of  paramyxoviruses 
is thought to be a homotetramer. Cross-linking studies com- 
bined with the use of nonreducing gels indicated that the HN 
protein consists of disulfide-linked dimers that form either 
noncovalently linked tetramers or disulfide-linked tetramers 
(36). In electron micrographs of purified HN, four subunits 
forming a homotetramer could be readily identified (65). 
To investigate the  rate of oligomerization of HN,  SVS- 
infected cells were pulse-labeled for 5 rain with Tran['S]- 
label and incubated for varying periods from 0-60 min in un- 
labeled chase medium. The oligomeric form of HN was then 
analyzed by sucrose density gradient centrifugation. Cell ly- 
sis buffers and sucrose density gradient solutions were ad- 
justed to pH 5.0 (approximately the pH optimum of the HN 
neuraminidase activity [62]), because at higher pH the HN 
oligomer partially dissociated under the centrifugation con- 
ditions used (data not shown). Fractions were collected from 
the bottom of the gradients and alternate fractions were im- 
munoprecipitated with the polyclonal HN antibody and the 
polypeptides were analyzed by SDS-PAGE. Immediately af- 
ter the labeling period, HN was found in a slow sedimenting 
peak  (Fig.  1 A,  fractions  12-16).  After 30 min of chase 
period,  approximately half of HN  was  found  in  a  faster 
sedimenting form (fractions 6-8). By 60 rain, >90% of HN 
had been converted to this faster sedimenting form. In a par- 
allel gradient, the trimeric influenza virus HA had a similar 
rate of sedimentation to oligomeric HN (data not shown). 
This analysis suggests HN is assembled into a higher order 
structure and this process has a t~ of ,~ 25-30 min. To gain 
further insight into the nature of the oligomeric form, immu- 
noprecipitated HN was analyzed under nonreducing condi- 
tions on SDS-PAGE (Fig.  1 B).  SV5 HN from the slower 
sedimenting peak (fractions 14-16) was found to migrate on 
gels with a similar but slightly altered mobility as compared 
with reduced monomeric HN due to intramolecular disulfide 
bonds. SV5 HN from the faster sedimenting form (fractions 
6-8) was found on gels to consist of two species, disulfide- 
linked dimers and tetramers (Fig.  1 B, HN2 and HN4), sug- 
gesting that this species on the gradient is a homotetramer 
consisting of pairs of disulfide-linked dimers that sometimes 
form a disulfide-linked tetramer. Although this does not for- 
really prove that HN of SV5 is a tetramer, for purposes of 
discussion, this will be assumed to be the case. The oligo- 
merization rate for SV5 HN is fairly slow as compared to that 
found for influenza virus HA or VSV G  (t,~ 7-10 and 6-8 
rain, respectively) (14, 5) but even so, it was not possible to 
distinguish between the rate of formation of  the oligomer and 
the rate of formation of the intermolecular disulfide bonds. 
Characterization of mAbs as Reagents to Detect Steps 
in the Folding  and Oligomerization of  HN 
In several other studies on the intracellular transport of gly- 
coproteins, extensive use has been made of mAbs to probe 
the folded state of the protein (5, 6, 14, 42, 70, 72). To search 
for mAbs that could recognize conformation-specific forms 
of HN,  a  panel of mAbs  prepared to  SV5  HN  (56)  was 
Ng et al. lntraceUular  Maturation  and Transport  of HN  3275 Figure I. Kinetics of SV5 HN oligomerization.  SV5-infected 
CV1  cells  at  16 h  p.i.  were  pulse-labeled  for 5  min with 
Tran[35S]-label. The cells  were then incubated  for varying 
periods in chase medium containing unlabeled  cysteine and 
methionine  and lysed in Triton X-100. The lysates were then 
subjected  to sucrose velocity sedimentation  on 7.5-22.5 % 
wt/vol  sucrose gradients  at 20°C for 20 h at 38,000 rpm. 
Fractions were collected from the bottom of each gradient 
and aliquots  from alternate  fractions were immunoprecipi- 
tared  with  HN polyclonal  antisera  and  analyzed by SDS- 
PAGE. (A) Samples treated  with the reducing agent  DTT. 
Times after the labeling  period are indicated.  (B) Samples 
electrophoresed  under  nonreducing  conditions  (-D/T). 
The  positions  of monomeric  (HNO,  dimeric  (HN2), and 
tetrameric  (HN4) forms of HN are indicated.  Times  after 
the labeling  period are indicated. 
screened.  SV5-infected cells  were pulse-labeled  for 5  rain 
with Tran[35S]-label and chase medium was added for vary- 
ing periods. The reactivity of the mAbs with HN at different 
time points was tested by immunoprecipitating samples with 
the polyclonal HN antibody or with each of the mAbs and 
analyzing the polypeptides  on SDS-PAGE under  reducing 
and nonreducing conditions. An example of the time course 
of reactivity of HN to a  polyclonal antisera and two mAbs 
The Journal of Cell Biology, Volume 109, 1989  3276 Figure 2.  Time course of reactivity of antibodies with HN. SV5-infected CVI cells were pulse-labeled at 14 h p.i.  with Tran[35S]-label 
for 5 min and incubated for the times indicated in chase medium containing unlabeled cysteine and methionine and lysed in RIPA buffer 
(30). Aliquots from each time point were used for immunoprecipitation with the different antisera. Following binding of immune complexes 
to protein A-containing agarose beads, the samples were analyzed by SDS-PAGE either in the presence (+/Y/T) or absence (-D/T) of 
DTT. (A) Immunoprecipitation with polyclonal HN antiserum that recognizes all forms of HN. (B) Immunoprecipitation with mAb HN-Ib. 
(C) Immunoprecipitation with mAb HN-4b. 
is shown in Fig. 2. The x-ray films were deliberately over- 
exposed to show the differences in reactivity. The polyclonal 
HN  antibody was  capable of immunoprecipitating mono- 
meric HN immediately after the 5-min labeling period (Fig. 
2 A) but the disulfide-linked dimers (and tetramers) did not 
begin  to  form  for  15  min  after the  labeling period.  The 
changes in mobility of HN with increasing period of chase 
(Fig. 2 A,  +DTT) reflect carbohydrate trimming and for the 
unreduced monomeric HN they also reflect the formation of 
intramolecular disulfide bonds (Fig. 2 A, -DTT). When the 
mAbs were used to immunoprecipitate HN from the same 
cell lysates neither antibody HN-lb nor HN-4b immunopre- 
cipitated HN immediately after the 5-min pulse period. After 
2.5 min of chase, antibody HN-lb began to gain reactivity 
to HN and after 5 min antibody HN-4b began to gain reactiv- 
ity to HN (+DTT, B and C). Reactivity of both mAbs to HN 
increased with extended times of chase period and by 60 min 
the amount of HN immunoprecipitated reached similar lev- 
els to that precipitated by the polyclonal HN antibody. When 
the samples were analyzed under nonreducing conditions on 
gels (Fig. 2,  -DTT) the difference between the specificity 
of the mAbs became clearer. Antibody HN-1B recognized 
monomeric HN at times (2.5-15 min) before the dimer had 
formed, whereas antibody HN-4b showed nearly exclusive 
reactivity with the dimer (Fig. 2  C).  Thus, the polyclonal 
HN antibody can recognize all forms of HN, mAb HN-lb 
recognizes an  epitope that  forms in  the  monomer and  is 
maintained in the disulfide-linked dimer and HN-4b has al- 
most exclusive reactivity with the dimeric (and tetrameric) 
form.  Because  the  formation  of intermolecular disulfide 
Figure 3. Reactivity of monoclonal antibodies to monomeric and oligomeric forms of HN. Relevant samples from the same sucrose gradient 
analysis as shown in Fig. 1 A were chosen for immunoprecipitation with the polyclonal HN antibody or the mAbs HN-Ib or HN-4b. Three 
time points after the labeling period were chosen for analysis (15, 30, and 60 min) and only the relevant alternate fractions are shown. 
Fractions 6-8 contain the oligomerized form of HN and fractions 12-16 contain the monomeric HN. 
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doglycosidase H. SV5-infected CV1 cells at 16 h p.i.  were labeled 
with Tranl3~S]-Iabel for 15 min. The cells were then incubated for 
the times indicated in chase medium and lysed in 1% SDS. The ly- 
sates were then immunoprecipitated with the polycional HN anti- 
body, digested with Endo H and analyzed by SDS-PAGE. Lane M, 
SV5-infected cell marker polypeptides as in Fig. 4; lane Tn, un- 
glycosylated HN marker  (HN immunoprecipitated  from infected 
cells treated with tunicamycin). 
bonds appears to coincide with oligomerization,  it is likely 
that HN-lb binds to an epitope that forms before oligomeriza- 
tion,  whereas HN-4b recognizes an epitope that is formed 
only after oligomerization. To test this possibility, the mAbs 
were used to immunoprecipitate HN after a 5-min pulse fol- 
lowed by chase periods of 15, 30, and 60 min and fraction- 
ation on sucrose density gradients. Only those fractions con- 
taining  HN polypeptide forms (fractions 6-16,  see Fig.  1) 
were analyzed by immunoprecipitation  using the polyclonal 
HN  antibody,  antibody  HN-lb,  or  antibody  HN-4b.  AS 
shown in Fig.  3,  after a  15-min chase period most of HN 
sediments in the slower monomeric peak (fractions  12-16). 
The mAb HN-lb was reactive with a fraction of HN found 
in these fractions, whereas HN-4b showed no detectable re- 
activity with these fractions (cf. lane 16 at 15 min). After 30 
and 60 min of chase period, both mAbs were fully reactive 
to HN found in the faster sedimenting tetrameric peak (frac- 
tions 6-8), but again only HN-Ib showed any reactivity with 
the material at the top of the gradient.  Thus, these data indi- 
cate that the two mAbs have different conformational  spe- 
cificities: HN-Ib recognizes a folded form of HN that forms 
before but is also present after oligomerization and HN-4b 
is specific to the oligomeric form. 
Rate of Transport of HN to the Medial Golgi Complex 
N-linked carbohydrate chains are modified from simple to 
complex carbohydate forms in the Golgi complex,  and the 
presence of carbohydrate chains resistant to digestion with 
endo-fl-N acetylglucosaminidase H (Endo H) is indicative of 
transport  of the glycoprotein through the medial Golgi ap- 
paratus (reviewed in reference 26). To determine the rate of 
transport of HN to the medial Golgi, SVS-infected cells were 
labeled for 15 min with Tran[3~S]-label,  incubated for vari- 
ous chase periods, the lysates were immunoprecipitated with 
the polyclonal HN antibody and immune  complexes were 
digested with Endo H. AS shown in Fig. 4, Endo H resistant 
forms of HN were not detected until 60 rain of chase period. 
Untreated  HN and  unglycosylated  HN  synthesized  in  the 
presence of tunicamycin were used as markers.  Two Endo 
H-resistant  bands  with  decreased electrophoretic  mobility 
were observed in comparison to the 0-rain time point.  HN 
contains four N-linked carbohydrate chains and it has been 
found that the two Endo H-resistant species represent poly- 
peptides containing either one or two carbohydrate chains of 
the complex type respectively (Ng D. T. W., S. W. Hiebert, 
and R. A.  Lamb, manuscript in preparation).  After longer 
chase periods,  the amount of Endo  H  resistant  forms  in- 
creased but they did not become a  single form, indicating 
heterogeneity at the same site of  N-linked sugar addition with 
different molecules having different carbohydrate modifica- 
tions i.e., simple or complex. Although not typical, this type 
of observation has been made previously, e.g.,  Thy-1  (55). 
In addition,  a population of HN molecules did not acquire 
Endo H resistance, but in experiments in which antibody was 
bound to infected cell surfaces,  it was found that this  un- 
modified species does become transported to the cell surface 
(data not shown) and it does not represent a form of oligo- 
merized HN blocked in transport in the Golgi complex. The 
presence of the multiple species on Endo H treatment made 
it difficult to  measure  the  precise  rate of transport  to the 
medial Golgi complex.  However, for purposes of compari- 
son to other proteins, these data indicate that the rate is rela- 
tively slow, because for those molecules that become Endo 
H resistant, <50% of  the molecules become Endo H resistant 
in 60 min. 
SubceUular Localization of  HN Oligomerization 
Oligomerization of HA and G  occurs rapidly (t~  7-10 and 
6-8 rain, respectively) and it has been shown to occur in the 
ER (6-8,  14). In comparison, HN has a relatively slow rate 
of oligornerization  (t,~ 25-30  rain).  As the correct folding 
and  oligomerization  of integral  membrane  proteins  have 
been suggested to be prerequisites for the transport of pro- 
reins out of the ER (14, 28), it was of interest to determine 
the subcellular site of HN oligomerization.  To test whether 
oligomerization  of  HN  occurs  before  or  after  transport 
through  this  compartment,  HN  was  immunoprecipitated 
from alternate sucrose gradient fractions (fractions 6-16) af- 
ter a 5-rnin pulse-label and varying chase periods, and HN 
in  the  immune  complexes was digested  with  Endo  H.  As 
shown in Fig.  5, after 5- and  15-rain chase periods,  when 
most of HN sedimented at the monomeric position, HN was 
The Journal of Cell Biology,  Volume 109, 1989  3278 Figure 5. Oligomerization of HN occurs prior to transport to the medial Golgi complex. SV5-infected CVI cells at 16 h p.i. were pulse- 
labeled for 5 min with Tran[35S]-label  and chased for 0-60 min. At the times indicated, lysates were prepared and fractionated on sucrose 
velocity gradients. Aliquots from alternate fractions of the relevant region of the gradient were immunoprecipitated with the polyclonal 
HN antibody and subjected to digestion with Endo H as described in Materials and Methods. M, direct lysate of SV5-infected cells as 
molecular weight markers: HN, 66,000; NP, 61,000; P, 44,000; and M, 38,000. U, control immunoprecipitated HN marker; T, HN synthe- 
sized in the presence of tunicamycin as an unglycosylated HN marker. Fraction numbers from each gradient (6-16) are indicated. 
entirely Endo H sensitive. After 30 min of  chase period, when 
approximately  half of the  molecules  had  assembled  into 
tetramers, HN still remained Endo H  sensitive.  Only after 
60 min of chase period could Endo H-resistant forms of HN 
be found in the tetrameric position on the gradient (Fig. 5, 
arrowheads). Thus, these data suggest that only oligomeric 
forms of HN are transported to the medial Golgi apparatus. 
The rate of oligomerization (t,~ 25-30 min) and the rate of 
acquisition of Endo H resistance (t,~ >60 min) suggests that 
oligomerization occurs before transport through the medial 
Golgi complex. 
Transport between the ER and the Golgi complex is an 
energy-dependent process that requires ongoing ATP pro- 
duction (64). CCCP, an uncoupler of oxidative phosphoryla- 
tion, has been used to block the transport of proteins from 
the ER (13) and hence its use makes it possible to study the 
oligomeric form of a protein in the ER (6). To examine fur- 
ther the intracellular site of oligomerization, SV5-infected 
cells were pulse-labeled for 10 min with Tran[35S]-label and 
incubated in the absence or presence of CCCP for 2  h  in 
chase medium and then immunoprecipitated with the poly- 
clonal HN antibody or with the oligomer-specific HN-4b. 
Half of  each immune complex was digested with Endo H be- 
fore samples were analyzed by SDS-PAGE. As shown in Fig. 
6, HN was reactive with the HN-4b monoclonal antibody in 
the presence of CCCP (+).  The block in transport to the 
medial Golgi complex from the ER in the presence of CCCP 
(+) was confirmed by finding that HN remained sensitive to 
Endo H digestion, whereas in the absence of CCCP (-), HN 
acquired Endo H  resistance.  The recovery of HN precipi- 
tated with the HN-4b mAb after CCCP treatment was not as 
great as with the polyclonal HN antibody, which suggests 
that a small fraction of molecules was unable to oligomerize 
in the presence of the drug and some monomeric HN was 
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CCCP does not block oligomer- 
ization. SV5-infected  CV1 cells at 
14 h p.i.  were pulse-labeled for 
10 min with Tran[35S]-label. The 
cells were then incubated at 4°C 
with  preehilled  chase  medium 
with (+) or without (-) CCCP 
(50/~g/ml) for 10 min and then the 
cultures were shifted to 370C for 
2 h. The cells were then lysed in 
RIPA buffer and aliquots immu- 
noprecipitated  with  either  the 
polyclonal HN antibody or mAb 
HN-4b. Immune  complexes  bound 
to  protein  A-containing agarose 
beads were either untreated (-) 
or digested (+) with Endo H. M, 
SV5  marker  polypeptides as  in 
Fig. 5;  P,  polyclonal HN  anti- 
body; 4b, mAb HN-4b. 
found on sucrose gradient analysis (data not shown). This 
may indicate a requirement for ATP in folding and oligomer- 
ization as  has  been suggested previously for VSV  G  (7). 
Thus, although these data do not prove, they strongly suggest 
that oligomerization of HN occurs in the ER before its trans- 
port to the Golgi complex. 
The Specific and Transient Association of  GRP78-BiP 
with HN before Oiigomerization 
We were interested to determine if the resident ER protein 
GRP78-BiP has a role in the maturation of the HN protein. 
In particular, we wished to define whether GRP78-BiP had 
a specific and transient interaction with HN or if GRP78-BiP 
only associated with malfolded proteins. 
To radioactively prelabel as many as possible of the slowly 
turning over GRF78-BiP molecules, CV1 cells were labeled 
with [3~S]methionine under steady-state conditions for 24 h. 
The  cells  were  then  infected  with  SV5  and  steady-state 
[35S]methionine labeling conditions were continued for 16 h 
p.i. to label all the HN molecules to a similar extent. Samples 
were then immunoprecipitated with either the polyclonal HN 
antibody or the mAbs HN-lb or HN-4b. AS shown in Fig. 
7, lane 4, in addition to HN, the polyclonal antisera coprecip- 
itated a prominent band that comigrates with GRP78-BiP. The 
polyclonal HN antibody did not precipitate GRP78-BiP from 
uninfected cells in which the synthesis of GRP78-BiP had 
been induced by tunicamycin treatment (Fig. 7, lane 1 ), sug- 
gesting that coprecipitation of GRP78-BiP and HN is spe- 
cific. The mAbs HN-Ib and HN-4b immunoprecipitated HN 
in amounts similar to that precipitated by the polyclonal HN 
antibody but no coprecipitation of GRP78-BiP was observed 
even after long exposures of the autoradiographs  (Fig.  7, 
lanes 5  and 6). This indicates that folded forms of HN, as 
defined by the mAb reactivities, were not associated with 
GRP78-BiP. To understand further the nature of the popula- 
tion of HN molecules that were associated with GRP78-BiP, 
sequential rounds of immunoprecipitations were performed. 
The lysate supernatants from the HN-Ib and HN-4b immu- 
noprecipitations were reprecipitated twice with the appropri- 
ate monoclonal antibody to assure complete removal of the 
reactive antigen (Fig. 7, lanes 9 and 10 [HN-lb]; lanes 11 and 
12, [HN-4b]) and then immunoprecipitated with the poly- 
clonal HN antibody, to recover immature and unfolded HN 
molecules not recognized by the mAbs. As shown in Fig. 7, 
lanes 7and 8, a subpopulation of HN molecules was precipi- 
tated by the polyclonal HN sera and it coprecipitated GRP78- 
BiP in an amount similar to that observed when the poly- 
clonal HN antibody was used on nonadsorbed lysates. These 
data suggest that this population of HN molecules recovered 
after preadsorption with the conformation-specific  HN-lb or 
HN-4b mAbs is in a complex with GRP78-BiP. As the mAb 
reactivity is gained with time after synthesis of HN, the mol- 
ecules associated  with  GRP78-BiP are thought to be un- 
folded and immaturely folded forms of HN. It can be ob- 
served in Fig. 7, lanes 7 and 8 that the subpopulation of HN 
molecules that coprecipitate with GRP78-BiP have a slightly 
slower electrophoretic mobility than the folded, nonassoci- 
ated form. This probably represents differences in carbohy- 
drate trimming between the immature and mature forms of 
HN and further illustrates the authenticity of  the two popula- 
tions of molecules. The polypeptide species seen in lanes 4, 
5, and 8 of M, '~34,000 and '~27,000,  and indicated by the 
arrows are proteolytic fragments of HN and they are dis- 
cussed further below.  The other readily identifiable band 
(Mr ,~44,000) is the SV5 P polypeptide, a small amount of 
which is precipitable by the polyclonal HN antiserum. Pre- 
adsorption of the lysate with an anti-P mAb (56) eliminates 
this band from the gel and does not affect the coprecipitation 
of HN and GRF78-BiP (data not shown). 
The amount of radioactivity in Fig. 7, lanes 6 and 7 was 
quantitated by densitometry of the autoradiograph and nor- 
malized with the known number of methionine residues in 
both HN and GRP78-BiP (24, 66, 67). A GRP78-BiP to HN 
ratio >0.7:1 was obtained. As the cells were only steady-state 
labeled for 40 h and the half-life of GRP78-BiP is >48 h (21), 
not all molecules of GRP78-BiP present in the ER may be 
The  Journal  of  Cell  Biology,  Volume 109,  1989  3280 Figure Z HN associates with the cellular protein GRP78-BiP. CV1 cells were steady-state labeled with [35S]methionine for 24 h as de- 
scribed in Materials and Methods. The cells were then infected with SV5 and steady-state labeling continued for a further 16 h. The cells 
were then lysed in Triton X-100  under ATlMiepleting  conditions and aliquots were immunoprecipitated with either the polyclonal HN anti- 
body (lane 4), mAbs HN-Ib (lane 5) or HN-4b (lane 6). Lysates absorbed with the rnAbs were sequentially immunoprecipitated a second 
and third time with the same respective antibodies (HN-Ib, lanes 9 and 10; HN-4b, lanes 11 and 12) to completely deplete the lysate of 
all HN molecules that were reactive with the mAbs. In the final serial immunoprecipitation, the preabsorbed lysates were incubated with 
the polyclonal HN antibody to immunoprecipitate HN species not reactive with the rnAbs. Lane 7, lysate depleted of  antibody HN-lb reactive 
forms of HN; lane 8, lysate depleted of  antibody HN-4b reactive forms of HN. Control immunoprecipitations of steady-state labeled mock- 
infected CV1 cells treated with tunicamyein (1 tg/ml) (to induce high-expression levels of GRP78-BiP) were done with polyclonal HN anti- 
body (lane./), antibody HN-Ib (lane 2), and antibody HN-4b (lane 3). Lane U, direct lysate of uninduced steady-state labeled cells; lane 
L direct lysate of tunicamycin treated steady-state labeled cells. The arrow indicates GRP78-BiP, the asterisk indicates HN and arrowheads 
mark the positions of the Mr ~34,000 and ,x,27,000 degradation products of HN that are recognized by antibodies HN-Ib and the poly- 
clonal HN antibody but not antibody HN-4b; these species are discussed further below with respect to data shown in Fig. 9. 
labeled. Thus, the finding of a ratio of GRP78-BiP to HN of 
0.7:1 suggests that HN may form a  complex with one (or 
more) molecules of GRP78-BiP. 
To investigate whether GRP78-BiP transiently associated 
with HN as a normal event during the maturation of HN or 
if GRF78-BiP was only binding to malfolded HN molecules 
that were not recognized by the mAbs, the kinetics of associ- 
ation of GRP78-BiP with HN were examined with respect to 
HN folding. SV5-infected CV1 cells were pulse-labeled for 
5 min with Tran[3~S]-label  and incubated in chase medium 
for varying periods before lysis of the cells in ATP-depleting 
detergent  buffer.  Serial  immunoprecipitations  were  per- 
formed with the rat anti-BiP mAb (kindly provided by Drs. 
Linda Hendershot and John Kearney), the mAb HN-lb, and 
lastly anti-HN IgG. Based on the experiment described in 
Fig. 7, it was predicted that if GRP78-BiP had a specific but 
transient association with HN, the BiP antibody would co- 
precipitate HN in a time-dependent manner and before the 
conformation-specific monoclonal HN-lb would recognize 
HN. Immunoprecipitation with the polyclonal HN antibody 
was done in the third round of precipitations to recover all 
forms of HN not removed by the first two antibodies so that 
it was possible to account for all the labeled HN synthesized, 
especially as the association of  GRP78-BiP with HN is labile 
and multiple rounds of immunoprecipitation may dissociate 
some HN from GRP78-BiP. 
The results of this time-course experiment (Fig. 8) show 
that immediately after a 5-min pulse-label, the BiP antibody 
precipitates a large part of the labeled HN and thus it is in 
a complex with GRP78-BiP. With longer chase periods, HN 
loses its association with GRP78-BiP and is no longer copre- 
cipitated by the BiP antibody (Fig. 8 A). Concomitantly, HN 
gains its ability to react with the conformation-specific mono- 
clonal antibody (Fig. 8 B) and this is at the same rate as ob- 
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sient and occurs prior to complete folding and oligomerization. 
SVS-infected CVI cells at 16 h p.i. were pulse-labeled for 5 rain 
with Tran[35S]-label. The cells were then incubated in chase medi- 
um for the times indicated and lysed in Triton X-100 under ATP- 
depleting conditions. Nuclei and debris were removed by centrifu- 
gation and the supernatants were serially immunoprecipitated  with 
anti-BiP monoclonal antibody (A), followed by mAh HN-lb (B), 
and finally the polyclonal HN antibody (C). Lane M, SV5 protein 
markers (HN indicated by an asterisk); lane U, uninduced cell ly- 
sate; lane I, tunicamycin  treated cell lysate. GRP78-BiP  is indicated 
by an arrow. (D) quantitation  by laser-scanning  densitometry of HN 
in autoradiographs  from A and B. Open circle, HN associated with 
GRP78-BiP; filled circle, HN reactive with antibody HN-Ib. 
served without prior precipitation with the BiP antibody (see 
Fig. 2). The data shown in Fig. 8, A and B were quantitated 
by densitometric scanning and are shown in Fig. 8 D to show 
the inverse relationship between BiP antibody binding HN 
and the HN-lb antibody binding. Preadsorption of  the lysates 
with anti-BiP did not affect the results obtained with HN-lb 
as it was shown in Fig. 7 that HN-lb was not reactive against 
GRP78-BiP associated forms of HN. The small amount of 
GRP78-BiP that can be seen on the autoradiograph (Fig. 8 
B) is due to carrying over some anti-BiP/GRP78-BiP im- 
mune complexes in the procedure and it does not affect the 
result. The polyclonal HN antibody precipitated immature 
HN molecules ffig. 8 C) that were either not complexed or 
had dissociated from GRP78-BiP,  during the procedure. 
Of critical importance to the interpretation of these data is 
the quantitation of all the labeled HN molecules synthesized. 
It could initially be thought that the HN molecules shown in 
Fig. 8 A only represent malfolded HN molecules bound to 
BiP that are rapidly degraded in the ER and that only the im- 
mature HN molecules recognized by the polyclonal antisera 
(C) give rise to the mature species of HN recognized by the 
HN-lb antibody (B).  At 5  min chase,  the HN molecules 
shown in A are ~60% of the total HN molecules present in 
Bat 90 rain chase, and the HN molecules in Cat 5 min chase 
are ,~,40% of  the HN molecules shown in B at 90 min chase 
(there is lime degradation of HN until 60-90  min, when 
measured using a  5-rain pulse-label).  Therefore, although 
the molecules shown in C are maturing into the folded form 
shown in B, HN molecules originally associated with BiP (A) 
have to be maturing and contributing greatly to the popula- 
tion of HN molecules found in B and thus these data are in- 
consistent with these HN molecules being rapidly degraded 
in  the  ER.  Indeed,  artificially engineered malfolded HN 
molecules form a stable association with BiP that turns over 
slowly (t~  ~6  h)  (Ng  D.  T.  W.,  S.  Hiebert,  and R.  A. 
Lamb, manuscript in preparation).  Given the observation 
that it is difficult to coprecipitate all of the cellular GRP78- 
BiP protein complexes with the BiP antibody (21) and the 
caveat discussed above concerning dissociation of BiP-com- 
plexes during repeated precipitations, these data indicate that 
a large proportion, if not all, of HN associates with GRP78- 
BiP during, or shortly after, synthesis and dissociates from 
GRP78-BiP when it attains a folded conformation. Thus, it 
seems reasonable to suggest that the GRP78-BiP and HN in- 
teraction is specific and part of the normal maturation path- 
way of HN. 
Other polypeptide species were also observed to be copre- 
cipitated by the BiP antibody and these are presumed to be 
cellular polypeptides localized in the ER. However, in com- 
parison to HN they were found in very low abundance (data 
not shown). A specific association between GRP78-BiP and 
the SV5 F glycoprotein has not been observed. However, this 
does not rule out the possibility that this interaction exists, 
as the conditions used may not be suitable for detecting a 
transient association with F, as our preliminary results indi- 
cate that the maturation of F is more rapid than HN (data not 
shown). 
HN is Rapidly Turned Over in Cells 
In experiments in which SV5-infected CV1 cells were pulse- 
labeled and incubated for varying chase periods, it was ob- 
served that the amount of  HH precipitated declined with time 
(e.g. see Fig. 8 D). To investigate this further, infected cells 
were labeled for 15 rain with Tran[3~S]-label, incubated for 
up to 7 h in chase medium and HN immunoprecipitated with 
the polyclonal HN antibody. As shown in Fig. 9 A, HN is 
turned over with a t~ of 2-2.5 h. It seemed possible that the 
loss of HN would be attributable to shedding from cell sur- 
faces or to its incorporation into budding and released virus 
particles. However, this was not the case, as <1% of the total 
HN present at 0 time could be recovered from the medium 
after 7 h (data not shown). Longer exposures of the autora- 
The Journal  of Cell Biology.  Volume 109, 1989  3282 Figure 9. HN does not accumulate in infected cells and is turned- 
over. SV5-infected CV1 cells at 14 h p.i.  were labeled for 15 min 
with Tran[35S]-Iabel and incubated in chase medium for varying 
periods from 0-7 h. The cells were lysed in RIPA buffer and HN 
immunoprecipitated with the polyclonal HN antibody. Polypeptides 
were analyzed by SDS-PAGE. (A) autoradiograms like that shown 
in the insert, were quantitated by laser scanning densitometry and 
the average values from three experiments are plotted showing the 
percent maximum HN immunoprecipitated with time of chase in 
hours. (B) over exposure of time-course of stability of HN to show 
the HN cleavage products of Mr ,,o34,000 and ,o27,000, which are 
indicated by the arrowheads. The time of chase is indicated above 
each lane in hours. M, SV5 marker polypeptides as in Fig. 5. 
diograms from these experiments (Fig.  9 B) indicated the 
presence of two HN species (M, ,~34,000 and ,~27,000)  of 
which the amount recovered does not reflect the amount of 
HN lost. It seemed likely that the loss of HN is by a degrada- 
tive process and that these species are intermediates in the 
degradation of HN. It is interesting to note that these smaller 
HN  specific species could be immunoprecipitated by the 
HN-lb but not the HN-4b mAb (see Fig. 7, lanes 5 and 6), 
suggesting preservation of specific domains after cleavage. In 
parallel experiments, F, the other glycoprotein of SV5, was 
found to be relatively stable (data not shown). 
HN Is Extensively Internalized from the Cell Surface 
It has long been known that HN is expressed at the surface 
of SVS-infected cells and is incorporated into virus particles 
(see reference 4). However, the rapid turnover of HN made 
it difficult to determine its rate of arrival at the cell surface. 
We investigated the possibility that HN was internalized from 
the cell surface and transported to internal cellular compart- 
ments, possibly lysosomes, for degradation. To test this hy- 
pothesis, either mAb HN-lb or F-la was bound to the surface 
of SVS-infected cells and incubated at 4°C,  a  temperature 
that blocks internalization (63).  Unbound antibody was re- 
moved by washing the monolayers and the cells were then in- 
cubated in prewarmed media at 37°C in the presence or ab- 
sence of 100 ~tM  chloroquine.  At various times after the 
temperature shift, cells were processed for intracellular fluo- 
rescence.  The bound HN- or F-specific antibody was de- 
tected by staining  with FITC-conjugated goat anti-mouse 
IgG. As shown in Fig.  10, antibody bound to HN at the cell 
surface was internalized and localized in scattered intracellu- 
lar vesicles after 30 min (cf. A and D). After 60 min, the 
fluorescent vesicles were less dispersed and began to aggre- 
gate near the nuclei of cells (G) and by 120 min the staining 
pattern was perinuclear (J) and virtually identical to the in- 
tracellular staining pattern obtained when HN-lb antibody 
was bound directly to permeabilized cells (cf. Fig.  10 J  to 
Fig. 11 B). Mock-infected cells treated in parallel did not ex- 
hibit a similar staining pattern (Fig. 10, C, F,/, and L). Treat- 
ment of SV5-infected cells with the lysosomotropic agent 
chloroquine did not block internalization of antibody-bound 
HN. However, the stained vesicles became enlarged and re- 
mained dispersed  120 min after the temperature shift (Fig. 
10, B, E, H, and K) as would be expected if antibody-bound 
HN was localized to intracellular vesicles that were blocked 
in transport to lysosomes due to the chloroquine treatment 
(38).  Cell  surface fluorescent staining  of HN-lb antibody 
bound to HN provided further support for internalization. 
After binding of HN-lb to cell surfaces but before the tem- 
perature shift, the cell surface staining pattern was punctate 
(Fig. 10 M). After 120 min of incubation at 37°C cell surface 
staining was not observed (Fig.  10 P), which is consistent 
with internalization of the antibody. In contrast to the situa- 
tion with HN,  when the same experiment was performed 
using F-la antibody bound to the cell surface, the staining 
pattern before and  120 min after the temperature shift was 
similar (Fig. 10, N and Q). In addition the intracellular stain- 
ing pattern of F-la antibody, before and  120 min after the 
temperature shift did not differ significantly, although some 
faintly staining vesicles could be observed (Fig. 10, O and R). 
Although the above data indicate that HN is internalized 
from the cell surface when bound to antibody, whereas in the 
Ng et al. lntracellular Maturation and Transport of HN  3283 Figure 10.  HN-antibody complexes are rapidly internalized from the cell surface:  F-antibody complexes are stable.  Coverslips of SV5- 
infected CVI cells at 14 h p.i. were washed with prechilled PBS and incubated at 4°C to prevent glycoprotein transport and internalization 
of surface molecules,  mAbs specific to HN (HN-lb) or to F (F-la) were added to the cells at 4°C and allowed to bind surface antigen for 
30 min and then the cells were extensively washed in PBS at 4°C. The medium was replaced with prewarmed DME and the cells incubated 
at 37°C for varying periods.  Cells were fixed with formaldehyde for surface staining or fixed with formaldehyde and permeabilized with 
The Journal  of Cell Biology, Volume 109, 1989  3284 Figure 11.  HN internalization  is not antibody mediated.  SV5-infected cells  at 16 h p.i.  were incubated  with 100/~g/ml  cycloheximide  to 
inhibit  further protein  synthesis.  At various times  cells were fixed, or fixed and permeabilized,  for indirect  immunofluorescent  staining 
of HN or F as described in Materials and Methods.  The panels show HN cell surface staining (A, D, G, and J) and HN intracellular  staining 
(B, E, H, and K) at 0,  1.5, 3, and 4.5 h respectivelY after the beginning  of the cycloheximide  treatment.  Parallel  infected  cell  cultures 
were stained  for F at the cell  surface  (C, F, L  and L) at the same indicated  times.  Micrographs in each series  were both photographed 
and printed with identical  times  of exposure.  Bar,  10 #m. 
large part F is not, it does not exclude the possibility that the 
binding of antibody has an effect on this process. If HN fol- 
lows a degradative pathway rather than a  recycling pathway 
and this process is antibody independent,  then it should be 
possible to monitor the loss of HN from cell surfaces and 
from intracellular  vesicles when protein synthesis is inhib- 
ited.  To test this hypothesis,  SV5-infected cells at  16 h  p.i. 
were treated with the inhibitor of  protein synthesis cyclohexi- 
mide (100 #g/ml) which in CV1 cells is 98% efficient at in- 
hibiting protein synthesis (data not shown). At various times, 
acetone for intracellular  staining.  HN- and F-bound antibodies  were stained by the addition of fluorescein-conjugated  goat anti-mouse anti- 
body. The intracellular  staining pattern of antibody-HN complexes  internalized  from infected cell  surfaces  from 0 to 120 min following 
the temperature  shift are shown in A, D, G, and J. Infected cells treated with chloroquine are shown in B, E, H, and K, and mock-infected 
cells in C, F, I, and L and the times after the temperature  shift are indicated.  (M and P) Cell surface staining of HN before and 2 h after 
the temperature  shift,  respectively.  (N and Q) Cell surface staining of F before and 2 h after temperature  shift,  respectively.  (O and R) 
Intracellular staining  of F before and 2 h after the temperature  shift,  respectively.  Micrographs in each series  were both photographed 
and printed  with identical  exposure times.  Bar,  10 #m. 
big et al. lntracellular Maturation and Transport of HN  3285 Figure 12. HN coloealizes with a marker for lysosomes. SV5-infeeted  CVI cells at 16 h p.i. were incubated for 2 h in DME containing 
100 #g/ml of Texas Red (TR)-conjugated  ovalbumin. The cells were then fixed and permeabilized and stained for HN using monoclonal 
antibody HN-Ib and fluorescein-eonjugated  goat anti-mouse antibody. (A) Fluorescein staining of HN. (B) Texas red staining of ovalbumin 
in the same field of cells as A. Bar, 10 tzm. 
monolayers were fixed, or fixed and permeabilized, for in- 
direct immunofluorescence. The cells were then incubated 
with mAb HN-lb or F-la and stained with FITC-conjugated 
goat anti-mouse antibody. As shown in Fig. 11, HN staining 
was lost from the surface of cells with time, and was barely 
detectable 3 h after the cessation of protein synthesis (Fig. 
11, A, D, G, and J). The intracellular HN staining pattern 
also decreased over this period, suggesting that HN was be- 
ing degraded (Fig. 11, B, E, H, and K). The perinuclear HN 
staining pattern in this experiment was very similar to that 
observed when HN-antibody complexes were internalized. 
As expected, the cell surface staining pattern for the F glyco- 
protein was relatively unchanged over the 4.5-h period of 
treatment with cycloheximide (Fig.  11, C, F,, I, and L). To- 
gether, the data in Figs.  10 and 11  indicate that HN trans- 
ported to the cell surface in SV5-infected  cells is sorted for 
internalization away from the F glycoprotein. 
HN Colocalizes with a Marker  for Lysosomes 
To further define the sub-cellular localization of HN, double- 
label  immunofluorescence was performed with Texas Red 
(TR)-conjugated ovalbumin as an endocytic marker that is 
taken up by ceils nonspecifically and accumulates in lyso- 
somes  (32).  SV5-infected  cells  were  incubated with TR- 
conjugated ovalbumin (100 #g/ml) for 2 h and then formalde- 
hyde-fixed and permeabilized in acetone. HN was stained by 
the addition of the mAb HN-lb and FITC-conjugated goat 
anti-mouse IgG. Fig.  12 shows the fluorescein-labeled HN 
(A) and TR-conjugated ovalbumin (B) in the same field of 
cells. Most of the staining was found to be coincident, sug- 
gesting that HN is localized to lysosomes as well as endocytic 
vesicles. 
Discussion 
Several models for the intracellular sorting of proteins in the 
exocytic pathway have been proposed (reviewed in reference 
52). Because of the different rates of exit of proteins from the 
ER after synthesis, it has been argued that transport occurs 
via a selective mechanism requiring positively acting signals 
(12,  33).  Alternatively, it has been proposed that transport 
to the cell surface is by default and is mediated by a continu- 
ously moving "conveyor  belt" of  vesicles (bulk flow) from the 
ER to the cell surface and that sorting would be achieved by 
the specific retention of  proteins in the ER or Golgi apparatus 
(59,  71). This proposal is based on finding a very fast rate 
(t.~  10-20  min)  of transport  of a  synthetic glycopeptide, 
which is thought unlikely to contain selective and positively 
acting transport signals (71). However,  these two general 
schemes do not have to be mutually exclusive as polypeptides 
could be retained in the ER while they fold and oligomerize, 
and during this maturation process a positively acting trans- 
port signal could be formed that is necessary for exit from 
the ER. 
In our studies on the maturation and assembly of the class 
II integral membrane protein HN of the paramyxovirus SV5 
we found, using sucrose velocity gradient analysis and anti- 
bodies specific for different conformational forms of the pro- 
tein, that oligomerization occurred with a t~ of 25-30 min. 
Oligomerization of the majority of known membrane and 
secretory proteins is thought to occur in the ER (57). Support 
for the idea that HN oligomerization takes place in the ER 
was provided by finding that it occurred in the presence of 
the transport inhibitor CCCP, and also by the finding that 
whereas the t~ of oligomerization is 25-30 min, the t,h for 
gaining Endo H resistance is >60 min. This implies that HN 
oligomerizes long before it reaches the medial Golgi. Direct 
evidence for this was provided by finding that HN oligomers 
were formed before they acquired Endo H resistance and that 
HN monomers always remained Endo H sensitive. HN be- 
comes an oligomer slowly as compared with the rates of as- 
sembly of the influenza virus HA (t,h 7-10 min) (14) or VSV 
G (t,~ 6-8 min) (7).  Additionally, the rate of arrival of SV5 
HN at the medial Golgi complex is relatively slow has also 
been observed for the HN molecule of the related paramyxo- 
viruses,  Newcastle disease virus  and Sendai virus  (t~  60 
min) (41, 42), and this is in contrast to the rapid rates for VSV 
G and influenza HA (t~  15-20 min) (5, 35).  As the rate at 
which proteins traverse the Golgi complex and arrive at the 
cell surface is thought to be similar (12, 33), it seems possi- 
ble that the difference in rates of folding and oligomeriza- 
tion may account in part for the differences in exit time from 
the ER. 
The Journal of Cell Biology, Volume  109, 1989  3286 As the folding and oligomerization process of  HN is a rela- 
tively slow process, we were interested in investigating if the 
resident ER component GRF78-BiP recognized and inter- 
acted with HN during its maturation. We have found that a 
substantial amount of GRP78-BiP associates with unfolded 
forms of HN as judged by the reactivity of these species with 
the polyclonal HN antibody after depletion of all HN species 
reactive with the mAbs. The form of HN that interacts with 
GRP78 is monomeric and has not acquired Endo H  resis- 
tance (data not shown) as would be expected for the unfolded 
forms of HN. Quantitation of the molar amount of GRP78- 
BiP (labeled under steady-state conditions) that associates 
with HN, indicated a ratio >0.7:1. As GRP78-BiP has a half- 
life of >48 h (21), and thus it is difficult to label all molecules, 
it seems possible that all unfolded molecules of HN are as- 
sociated with one (or more) molecules of GRP78-BiP. The 
kinetic analysis of the HN/GRP78-BiP interaction strongly 
suggests that this association is  specific and transient  (t~ 
20-25 min), as GRP78-BiP was found complexed with HN 
during or immediately following its synthesis and dissocia- 
tion occurred when HN began to form its folded conforma- 
tion.  It has  been  found that ATP dissociates GRP78-BiP 
complexes in vitro (43). Addition of 1 mM ATP to the HN/ 
GRP78-BiP complexes caused dissociation of the interaction 
and the unfolded status of the HN molecules was confirmed 
by finding that these HN species did not react with the HN 
monoclonal antibodies (data not shown). These findings also 
argue against the possibility that GRP78-BiP was binding to 
the epitope recognized by the antibodies. 
The specific and transient association of GRP78-BiP with 
HN during its maturation pathway and the inverse correlation 
of this association with HN folding and oligomerization sug- 
gests that this is a normal role of GRP78-BiP, as was sug- 
gested previously for the assembly of immunoglobulins (1, 
20). The GRP78-BiP interaction with HN may be important 
to retain HN in the ER. During the slow process of folding 
and oligomerization, the resident ER protein disulfide iso- 
merase (2) is likely to be involved in the formation of com- 
plex intramolecular and intermolecular disulfide bonds, thus 
GRP78-BiP may prevent unfolded forms from entering the 
exocytic pathway. We speculate that the interaction of GRP78- 
BiP may be mediated by a "transient retention signal" in HN 
that is exposed during or shortly after translocation of HN 
into the ER but that is buried on folding of the molecule. Fur- 
ther evidence for a  role of GRP'/8-BiP in the  maturation 
of HN comes from work done with HN molecules lacking 
N-linked glycosylation sites. These altered molecules neither 
fold properly to gain reactivity with the monoclonal antibod- 
ies nor do they oligomerize and they are retained in the ER 
in a stable complex (t,~ ,06 h) with GRP78-BiP (Ng et al., 
manuscript in preparation). The finding that the association 
of GRP78-BiP with HN is part of its maturation pathway in 
the  ER,  supports  the proposal that GRP'/8-BiP may be a 
member of a  recently described group of proteins called 
chaperonins, which are involved in the posttranslational as- 
sembly of multi-subunit proteins (16, 19, 48). 
Our studies on the internalization of HN developed from 
the observation that HN is rapidly turned over in cells and 
this had made it difficult to determine the rate of transport 
of HN to the cell surface. Initially it was assumed that turn- 
over would be explained by the shedding of HN molecules 
from the cell surface or due to the incorporation of HN into 
budding virus particles but neither of these two possibilities 
were found to be correct. HN was found to be extensively 
internalized from the cell surface and became localized in in- 
tracellular vesicles and lysosomes. In the absence of synthe- 
sis of HN, fluorescent staining of lysosomes was lost with 
time, and together with the biochemical data for the turnover 
of HN, these data suggest that endocytosis of HN is of the 
nonrecycling type and that internalized HN is degraded in 
lysosomes. However, these data do not exclude the possibil- 
ity that some of the turnover of HN is attributable to its direct 
transport from the Golgi apparatus to lysosomes. Although 
both the SV5 HN and F glycoproteins must be close in prox- 
imity to form a patch on the cell surface for virus budding 
(see reference 4), HN must be sorted away from the F protein 
at the cell surface as F accumulates there. The HN internal- 
ization experiments were performed with SV5-infected CV1 
cells and these cells do not produce as many infectious parti- 
cles as MDBK cells (3, 49). Thus, it might be thought that 
HN  internalization would  affect the  number of maturing 
virus particles.  However, when the experiments were per- 
formed in SVS-infected MDBK cells it was found that HN 
had as rapid a rate of turnover as in CV1 cells (data not shown). 
Additionally, we have found that the turnover of HN is not 
dependent on the expression of other SV5 proteins as it oc- 
curs at a similar rate in CV1 cells that express HN from an 
SV40-HN recombinant vector (data not shown). 
Unlike the situation occurring with SV5, in cells infected 
with Sendai virus, a related paramyxovirus, internalization 
of HN does not seem to occur (60). However, in cells infected 
with a mixture of standard and defective Sendai virus parti- 
cles, in which there is a poor level of accumulation of the vi- 
ral matrix protein (M) it was found that HN was internalized 
and  it  was  hypothesized that  the  mechanisms  underlying 
these observations are  interconnected (60).  Retrospective 
analysis of photomicrographs showing fluorescent intracel- 
lular staining of the HN protein of the related mumps virus 
(70) show a vesicular pattern that is very similar to that found 
with SVS, which suggests that internalization of these viral 
type II integral membrane proteins may be a frequent occur- 
rence. 
The most common pathway for cellular plasma membrane 
receptors is that they are recycled to the cell surface after en- 
docytosis (reviewed in reference 15).  However, endocytosis 
and degradative processes are used by several cellular recep- 
tors e.g., IL-2 receptor (ll) and tumor necrosis factor recep- 
tor (68): these receptors internalize with and without ligand 
and are eventually degraded. Although the physiological sig- 
nificance of degradation of HN in tissue culture cell infec- 
tions with SV5 is presently unclear, in an animal infection 
it may have great importance in removing the highly immu- 
nogenic HN molecule from immune surveillance and caus- 
ing persistent infection by allowing cell to cell spread of  virus 
by the viral fusion activity. The SV5 HN molecule will also 
provide a useful model system for studying further aspects 
of the endocytosis/degradative pathway. 
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